​

Funding Round

Series B - NorthSea Therapeutics

Series B - NorthSea Therapeutics

Investment Firm

Overview

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Announced Date

Jan 08, 2020

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

venBio Partners

venBio Partners

venBio Partners is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorvenBio Partners
Participant InvestorSofinnova Investments
Participant InvestorNovo Holdings
Participant InvestorBioGeneration Ventures
Participant InvestorNew Science Ventures

Round Details and Background

NorthSea Therapeutics raised $40006979 on 2020-01-08 in Series B

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 12, 2017
Series A - NorthSea Therapeutics
4-29.4M
Jan 08, 2020
Series B - NorthSea Therapeutics
6-40.0M
Jan 01, 2019
Venture Round - NorthSea Therapeutics
1-undefined
Dec 17, 2021
Series C - NorthSea Therapeutics
8-80.0M

Recent Activity

There is no recent news or activity for this profile.